Recent Headlines
Cincinnati Children's Celebrates Patients and Families with Inaugural Five-Mile Pledge Walk
Thousands of patients, families and supporters of Cincinnati Children's Hospital Medical Center will gather at Coney Island from 10 am - 2 pm Saturday, November 4, for the inaugural Cincinnati Walks for Kids. This new fundraising initiative, designed to celebrate and honor the patients and... - August 25, 2006 - Cincinnati Children's Hospital Medical Center
Colorado BioScience Association Announces Winners of Its 2006 Awards Program, Honoring the Best of Colorado's Bioscience Industry
The Colorado BioScience Association (CBSA) has released winners of its 2006 Awards Program. Official presentation of the awards occurs Thursday evening, August 24, 6:30 – 8:30 p.m., at the CBSA’s annual awards banquet. Held in conjunction with the 2006 BioWest conference at the Colorado Convention Center, registration information is available at the 2006 BioWest Conference website. - August 18, 2006 - Colorado BioScience Association
The Crowded Field of VEGF and VEGF-R Targeting Drugs
The versatility of the vascular endothelial growth factor (VEGF) signalling pathway as a validated target and its excellent tractability explain a crowded field of drugs of all classes. - August 17, 2006 - La Merie Business Intelligence
A Full Pipeline of Follow-on TNF-Antagonists
The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies. - August 02, 2006 - La Merie Business Intelligence
Five Top Colorado Bioscience Company CEOs Present at This Year’s BioWest Investor Forum
CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2006 Investor Forum on August 24th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Investor Forum include Paul Berns, Allos Therapeutics; John Serino, Encision; Bill Freytag, Myogen; Patrick Mahaffy, Pharmion; and Ken Collins, Replidyne. - July 28, 2006 - Colorado BioScience Association
Seven Finalists Selected for The BioWest 2006 Venture Showcase Competition, Presenting World-Changing Technologies
Novel cancer drugs; innovative treatments for blood cancers and clotting; new ways to attack inflammatory and infectious diseases; ground-breaking compounds to treat osteoporosis and metastatic bone disease; pioneering devices for orthopedic surgery; commercializing biofuels from algae; and revolutionary wearable rehabilitation systems comprise the seven finalists in this year’s BioWest Veture Showcase competition. - July 11, 2006 - Colorado BioScience Association
Biogenerics and New Technologies Compete with 1st Generation Major Products
The US$ 32 bln market of six major protein products is enfacing competition by less costly biogenerics and by improved products via drug delivery or protein engineering technologies and even oral, small molecule solutions. - June 20, 2006 - La Merie Business Intelligence
Baxter Black and Ira Flatow Lead the Lineup of Presenters for Biowest 2006, Now Open for Registration
Registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2006. More than 750 participants are expected at this year’s event, August 23-24, at the Colorado Convention Center in Denver. America’s “Cowboy Poet” Baxter Black and NPR Science Friday® host Ira Flatow are the headliners for Biowest 2006, along with the presentation, “Where Innovation Happens” from Federal Reserve Executive Michael Orlando. - June 06, 2006 - Colorado BioScience Association
Imminent Launches of New EPO Products and Consolidation of the Biogenerics Field
The Business Intelligence firm La Merie S.L. reported today changes in the field of erythropoiesis stimulating agents (ESA) observed in a follow-up analysis. The first launch of a new ESA in Europe is expected to be Shire’s epoetin omega in the first half of 2007 to be followed by... - June 03, 2006 - La Merie Business Intelligence
Localized Delivery of PDE-4 Inhibitors to Open the Therapeutic Window
The Localized delivery of phosphodiesterase-4 (PDE-4) inhibitors appears to be short term solution to overcome the dose-limiting side effects of severe nausea and emesis occurring after oral administration. In the long-term, subtype-selective PDE-4 inhibitors and combination regimens may help to improve the therapeutic index. - May 31, 2006 - La Merie Business Intelligence
WellAware™ Error-Free Light Guided Manual Pipetting System is Now Application Based
BioTX has finished the development of an application based, light guided manual pipetting system called WellAware which is ideal for forensic, paternity, life science, pharmaceutical, preclinical and chemistry labs. WellAware provides lab managers with an inexpensive alternative or supplement to full automation. WellAware is configured right out of the box for PCR, DNA sequencing, genotyping, microplate transpositions, dilutions, normalizations, microplate reformatting and cherry-picking. - May 25, 2006 - BioTX Automation, Inc.
The Next Generation of Interferons Needs Improvement in Efficacy and Safety
The interferon alpha market is smaller than the interferon beta market, but is characterized by far more products and R&D projects. Conversion of the interferon alpha market to pegylated products explains why new R&D is focused on interferon alpha variants or other subtypes with improved pharmacodynamic and safety properties. - May 19, 2006 - La Merie Business Intelligence
First DNA Testing Lab to Promise Fast Results with a Money-back Guarantee
New paternity test guarantee may benefit more than 1 million people each year. - May 18, 2006 - Identigene
RNA Interference (RNAi) is Coming of Age as a Therapeutic Modality
The Business Intelligence firm La Merie S.L. reported today that the RNAi therapeutic pipeline is rapidly filling and advancing towards clinical development. Four RNAi therapeutic projects are in early clinical development. At least 32 RNAi projects are in preclinical development in a variety of... - May 10, 2006 - La Merie Business Intelligence
BioWest 2006 Organizers Seek the Best and Brightest of the Rocky Mountain Region’s Bioscience Start-Ups for the Venture Showcase Competition
BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Seven companies will be chosen to present at the Showcase in August, which will be judged by a panel of national venture capitalists. Deadline for entry is June 8, 2006. - May 09, 2006 - Colorado BioScience Association
2006-2007 Colorado Bioscience Magazine Unveiled At Colorado BioScience Association 2006 Annual Membership Meeting
Colorado BioScience Association released new 76-page issue of Bioscience Colorado Magazine at the 2006 Annual Membership Meeting. In addition, seven new appointments were made to the Board of Directors, along with eight reappointments; 2006 Corporate Sponsors were introduced; and Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award. - April 18, 2006 - Colorado BioScience Association
Seven New Board Members Named To The Colorado BioScience Association Board Of Directors At The 2006 Annual Membership Meeting
Seven new appointments were made to the Board of Directors of Colorado BioScience Association at its 2006 Annual Membership Meeting, along with eight reappointments. In addition, the 2006 Corporate Sponsors were released; Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award; and the 2006-2007 Bioscience Colorado Magazine was unveiled to members at the event. - April 18, 2006 - Colorado BioScience Association
State Senator Brandon Shaffer Receives National BIO Legislator of the Year Award at Colorado BioScience Association 2006 Annual Membership Meeting
Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award at the Colorado BioScience Association 2006 Annual Membership Meeting. The award was presented by Amgen Colorado’s Eric Bergenson. Senator Shaffer was singled out nationally for his ongoing and extensive support of the bioscience industry in the state. - April 18, 2006 - Colorado BioScience Association
Antibodies are the First Wave of IGF-1R Antagonists for Cancer Therapy
At least six fully human or humanized antibodies against insulin-like growth factor-1 receptor (IGF-1R) are in early clinical development or close to phase I. - March 07, 2006 - La Merie Business Intelligence
Dawn has Broken for Obesity Treatment with Cannabinoid Receptor (CB1) Antagonists
Tremendous impetus to discovery of novel CB1 antagonists by first-in-class CB1 receptor antagonist rimonabant under review by FDA and EMEA - February 22, 2006 - La Merie Business Intelligence
Top 20 Biologics Now with Sales of US$ 37.7 Bln in 2005
The Top 20 blockbuster recombinant proteins and antibodies achieved record sales of US$ 37.7 bln in the year 2005 while combined sales of the 12 Top selling classes of recombinant proteins and antibodies reached the US$ 50 bln threshold. - February 15, 2006 - La Merie Business Intelligence
Dosing Convenience Mandates the Pipeline of Glucagon-like Peptide-1 (GLP-1) Analogs for Type 2 Diabetes
Twice-daily injection is the benchmark set by exenatide, the first GLP-1 analog launched in the US by Lilly in June 2005 and half-year sales of US$ 74.6 mln, which now faces competition by GLP-1 analog treatment modalities with less frequent dosing. - February 07, 2006 - La Merie Business Intelligence
Emerging Diabetes Drugs in Early Development
The complexity of glucose metabolism and the number of cellular processes affected by diabetes provides ample space for new drug targets and for first-in-class molecules. Some of them have reached or are close to early clinical development in type 2 diabetes. - January 31, 2006 - La Merie Business Intelligence
High Interest in Inhibitors of the Novel Target Sodium-dependent Glucose (co-) Transporter (SGLT) for Therapy of Type 2 Diabetes
A plethora of SGLT inhibitors in the patent literature and seven compounds in early clinical development indicate an abundance of interest in the therapeutic use of SGLT inhibitors for the treatment of type 2 diabetes. SGLT inhibitors do not intervene with glucose metabolism, thus being complementary to mainstream approaches to glucose regulation, i.e. PPAR agonists, DPP-IV antagonists and GLP-1 analogues. - January 24, 2006 - La Merie Business Intelligence
Pharm-Olam International Announces $13.4 Million Contracts to Provide Services for Clinical Trials
Pharm-Olam International Ltd. (POI), a multi-national CRO to pharmaceutical, biotechnology and medical device industries, announced the signing of three contracts with an aggregate value of $13.4 million. The contracts involve patient recruitment, site selection, project management, biostatistics, monitoring, and regulatory affairs in the therapeutic areas of pain, cardiovascular disease, and ophthalmology. - January 11, 2006 - Pharm-Olam International
Herbion and Uzbek Health Sector Delegation – An interesting Get Together
Continuing its hospitable tradition, Herbion Pakistan Pvt. Ltd. organized a memorable event extending a warm welcome to the members of Uzbekistan Health Sector Delegation on the pleasant evening of December 13, 2005 by having Corporate get together followed by an interesting boat ride and dinner. - December 17, 2005 - Herbion International
Hamdard University Students Study Tour Herbion
A group of 16 students and 3 faculty members from Hamdard University, Karachi, Pakistan visited Herbion Pakistan (Private) Limited, the manufacturing unit of the Herbion Group of Companies located at Korangi, Karachi on December 8, 2005. - December 16, 2005 - Herbion International
Christine Shapard To Leave Governor’s Office In January To Join Colorado BioScience Association
Christine Shapard, Director of Biosciences and Emerging Technologies for the Governor’s Office of Economic Development and International Trade (OEDIT) for the past two years, will join the Colorado BioScience Association (CBSA) in January as the association’s Director of Marketing and Communications. During 2006, Shapard will maintain a 25% appointment with OEDIT tracking and completing major efforts currently in progress. - December 09, 2005 - Colorado BioScience Association
Pharm-Olam International Releases Results of 2005 Client Satisfaction Survey
Revealing continuing improvement in levels of customer satisfaction and loyalty, Pharm-Olam International Ltd. (POI), a multi-national CRO to pharmaceutical, biotechnology, and medical device industries, has released the most recent results of its formal survey. - December 09, 2005 - Pharm-Olam International
Cardiovascular safety determines the direction of PPAR agonist R&D
The two peroxisome proliferator-activated receptor (PPAR) gamma agonists pioglitazone and rosiglitazone approved for treatment of type 2 diabetes achieved combined 2004 global sales of US$ 3.96 bln shared between Takeda & Eli Lilly (52 %) and GlaxoSmithKline (48 %). - November 28, 2005 - La Merie Business Intelligence
Pharm-Olam International Completes Enrollment of 700 Patient Global Pivotal Phase III Clinical Trial for Metastatic Breast Cancer
HOUSTON, TEXAS – November 27, 2005 – Pharm-Olam International Ltd. (POI) has completed enrollment of a 700 patient pivotal trial for the treatment of metastatic and recurrent breast cancer. Enrollment of the Phase III clinical trial was achieved on schedule in just 18 months and... - November 25, 2005 - Pharm-Olam International
Competition is Needed in the Follicle Stimulating Hormone (FSH) Market
Ten years after the first approval of a recombinant human FSH for treatment of infertility the US$ 0.9 bln global market of recombinant human FSH (rhFSH) in 2004 was shared between Serono (63 % for follitropin alfa) and Organon (37 % for follitropin beta). - November 14, 2005 - La Merie Business Intelligence
InViragen Wins The First Annual Faegre & Benson Venture Showcase Award, Presented At BioWest 2005
Fort Collins-based InViragen LLC has won the first annual Faegre & Benson Venture Showcase Award at the BioWest 2005 conference in Denver. The announcement is made by Chris Shapard, bioscience director at the Colorado Office of Economic Development and International Trade (OEDIT), who says the $10,000 Venture Showcase Award was provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards banquet held earlier this evening. - November 09, 2005 - Colorado BioScience Association
2005 Colorado BioScience Association Awards Honor The Best of Colorado's Bioscience Industry
The Colorado Bioscience Association (CBSA) is announcing winners of its 2005 Awards Program at a banquet currently underway at the Colorado Convention Center. Held in conjunction with the 2005 BioWest conference, the annual awards program honors the best of Colorado’s bioscience industry. - November 08, 2005 - Colorado BioScience Association
Colorado BioScience Association Features Replidyne, iBalance Medical, BioWest 2005 and the Recent Bioscience Forum in the Fall 2005 Edition of The CBSA FOCUS
Colorado BioScience Association (CBSA) has published the third issue of its quarterly newsletter, “The CBSA FOCUS.” Featured articles in the Fall 2005 publication cover BioWest 2005, Coming Events, Executive Report, iBalance Medical, Regulatory Update, Replidyne, Bioscience Forum, and News Briefs. The newsletter helps further share the many success stories and highlights of Colorado’s medical device and biotechnology industries. - October 28, 2005 - Colorado BioScience Association
SuperCharging DVD by Quantum-Touch Promises to Enhance Effectiveness of Practitioners of Energy Healing and Alternative Medicine
SuperCharging DVD by Quantum-Touch improves your Alternative Medicine practitice. - September 28, 2005 - Quantum Touch
DNAvision is the First European Pharmacogenomic Service Laboratory to Succeed ISO/IEC 17025 Audit
DNAVision laboratory, a BioVallée spin-off, announced today that it has succeeded an official audit under ISO Standard 17025. DNAVision will be the first full-service pharmacogenetic / pharmacogenomic DNA testing laboratory to receive this accreditation in Europe. ISO 17025 is an... - September 06, 2005 - DNAvision
Two Colorado Companies to Present at Midwest’s Largest Biotech and Medical Device Event
The Biotechnology Industry Organization (BIO) has selected two private companies from Colorado to present at the BIO Mid-America VentureForum – Longmont-based MicroPhage Incorporated and Aurora-based Thinc Pharmaceuticals. The conference takes place at the Minneapolis Hilton, September 21-23. - August 15, 2005 - Colorado BioScience Association
BioWest 2005 Expands to Feature Venture Capital Award
The Rocky Mountain Region's premier networking event and trade show for the biotechnology and medical devices industries has expanded to include the first annual $10,000 Faegre & Benson Venture Showcase Award, to be presented to the winning emerging biosciences company at the Venture Capital program on November 8, 2005. The award, sponsored by the law firm Faegre & Benson, is designed to help support growing biotech companies. - August 15, 2005 - Colorado BioScience Association
Colorado BioScience Association Announces The Second Annual Issue of Bioscience Colorado Magazine
Colorado Bioscience Association (CBSA) has released the 2005 edition of its annual four-color magazine, Bioscience Colorado. Published in collaboration with the Colorado Office of Economic Development and International Trade, the magazine is distributed at international conferences, such as BIO and AdvaMed, to national site selectors and throughout the local community. The magazine includes articles on the Colorado bioscience industry, plus a directory of all Colorado life science companies. - July 21, 2005 - Colorado BioScience Association
CBSA’s Denise Brown Is Now Profiled at the Expert Information for Journalists Website
Denise Brown, Executive Director of Colorado BioScience Association (CBSA), is now profiled on the Expert Information For Journalists website – Expert411.com. Brown provides expert perspective on the Colorado Bioscience Industry, including backgrounding regarding Colorado's biotechnology, pharmaceutical, medical device and agricultural biotech initiatives. She is also able to connect reporters to other individuals throughout the state for additional relevant information and expert commentary. - July 19, 2005 - Colorado BioScience Association
Colorado BioScience Association Endorses Referendums C & D In Its Summer 2005 Edition of The CBSA FOCUS
Colorado BioScience Association (CBSA) has published the second issue of its quarterly newsletter, “The CBSA FOCUS.” Featured articles in the Summer 2005 publication cover Referendums C & D; PR Pharmaceuticals based in Fort Collins; and William W. Cimino, Ph.D., President of Sound Surgical in Louisville. Other topics covered include upcoming CBSA events, executive report, CBSA’s public policy process, regulatory update on compliance as a competitive advantage, and news briefs. - July 19, 2005 - Colorado BioScience Association
Colorado BioScience Association and Biotechnology Industry Organization Jointly Sponsor August 9th Bioscience Forum
The Biotechnology Industry Organization (BIO) and Colorado BioScience Association (CBSA) are jointly sponsoring the Bioscience Forum on Tuesday, August 9, 2005, 10 a.m. to 1:30 p.m. , on the Fitzsimons Campus. This educational event focuses on the outlook of the Bioscience Industry in Colorado. Keynote Speakers include The Honorable Bob Beauprez (R-District 7-CO), The Honorable Andrew Romanoff, Speaker of Colorado House, and The Honorable James Greenwood, President & CEO, BIO. - July 19, 2005 - Colorado BioScience Association
Business Growth Sparks Quantum Touch Move from Hawaii
Explosive Business Growth Sparks Quantum-Touch Move from Hawaii. As much as they loved living in paradise on Kauai, the island simply got too small to contain the growth of Quantum-Touch. An energy healing technique that Alternative Medicine magazine called "a significant breakthrough," Quantum Touch is gaining huge popularity because it has been shown to reduce pain and complement traditional therapies to speed healing. - June 17, 2005 - Quantum Touch
Colorado BioScience Association Debuts Quarterly Newsletter: The CBSA FOCUS
Colorado BioScience Association (CBSA) has published the first issue of its quarterly newsletter, “The CBSA FOCUS.” Featured articles in the Spring 2005 issue cover the Colorado Technology Survey; McKinley Medical company’s new pain management product targeting the plastic surgery industry; and Dr. Michael Bristow, noted professor, physician and founder of both the Myogen and ARCA Discovery biotech companies. - May 31, 2005 - Colorado BioScience Association
Colorado BioScience Association Names Ed Wood Chairperson and Appoints Four New Board Members
Ed Wood, CEO of Summit Roundtable in Lakewood, CO, is the new Chairperson of the Board of Directors for the Colorado BioScience Association (CBSA). He was appointed at the Association’s 2005 Annual Meeting held in April. Wood assumes chairperson responsibilities from Ralph (Chris) Christoffersen, General Partner, Morgenthaler Ventures, Boulder, CO, office. Vice Chairperson of the board is Jack Wheeler, CEO of Microphage, Inc., Longmont, CO. - May 30, 2005 - Colorado BioScience Association
Herbion Pakistan "The Way to Health" Has Been Awarded the 28th Export Trophy 2003 - 2004 by "The Federation of Pakistan Chamber of Commerce & Industry"
It is a matter of great pleasure to share this significant achievement news that Herbion Pakistan "The Way to Health" has been awarded the 28th Export Trophy 2003 - 2004 by "The Federation of Pakistan Chamber of Commerce & Industry" in recognition of extra-ordinary dynamism,... - December 07, 2004 - Herbion International